Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
0 hedge funds and large institutions have $0 invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $5.26M → $0 (-$5.26M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.06M |
| 2 |
Walleye Capital
New York
|
-$1.15M |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$1.03M |
| 4 |
Walleye Trading
New York
|
-$647K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$190K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CF
1
Cantor Fitzgerald
New York
| – | -$1.03M | -1,035,000 | Closed |
|
|
2
Goldman Sachs
New York
| – | -$2.06M | -200,000 | Closed |
|
|
3
Walleye Capital
New York
| – | -$1.15M | -111,873 | Closed |
|
|
4
Walleye Trading
New York
| – | -$647K | -62,928 | Closed |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| – | -$190K | -18,454 | Closed |
|
|
CS
6
Clear Street
New York
| – | -$180K | -17,518 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$3K | -263 | Closed |
|
|
AF
8
Allworth Financial
Folsom,
California
| – | -$2.06K | -200 | Closed |
|
IQMD Hedge Fund Activity: Q2 2023 in Review
0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2023, worth a combined $0 — down 100% from $5.26M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IQMD and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Goldman Sachs, exiting entirely with an estimated $2.06M sold.
- 0 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2023, down from 8 in Q1 2023.
- Funds reported $0 of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2023 and 8 closed out, a net change of -8 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2023 was Goldman Sachs, an estimated $2.06M sold.
Based on aggregated 13F filings for Q2 2023.